About Acme Generics Private Limited
Data last updated:
Acme Generics Private Limited is a private limited company based in Mohali, Punjab, India, a subsidiary of Acme Formulation Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100PB2021PTC056566. Its GSTIN is 02AAVCA5625M1ZB (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹121.44 Cr and a paid-up capital of ₹120.1 Cr. It is led by directors Vikas Sharma (Whole-Time Director) and Viral Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 132 2nd Floor Sector 82 Jlpl, Mohali, Punjab, India – 140308.
As per the financials filed for FY 2024, the company reported a revenue of ₹263.78 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹8.48 Cr (net margin 3.2%) and EBITDA of ₹23.94 Cr (EBITDA margin 9.1%).
The company has about 2,455 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Acme Generics. As per MCA filings, the company has open charges of ₹116.08 Cr and satisfied charges of ₹95.53 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 2 filed against it; 4 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2022. The company has 6 MSME Form 1 returns on record between 2022 and 2024, listing 367 overdue payments to 37 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acmegenerics.in.
CIN History of Acme Generics Private Limited
Acme Generics has one previous CIN (Corporate Identification Number): U24100CH2021PTC043813. The current CIN is U24100PB2021PTC056566, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100PB2021PTC056566 | Current |
| U24100CH2021PTC043813 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 132 2nd Floor Sector 82 Jlpl, Mohali, Punjab, India – 140308
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Acme Generics Private Limited
Acme Generics operates one associated brand: Acme Generics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Solid and liquid formulations are manufactured as a CDMO focus. | acmegenerics.in |
Financials of Acme Generics Private Limited FY 2024 filings available
Acme Generics Private Limited reported revenue of ₹263.78 Cr (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Acme Generics Private Limited
Revenue rose 1% in the latest year. EBITDA fell 24% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Acme Generics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | ₹263.78 Cr | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹23.94 Cr | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.48 Cr | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Acme Generics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 9.1% | •••• | •••• |
| Net Profit Margin | 3.2% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acme Generics are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Acme Generics Private Limited
Acme Generics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Sharma Also directs: Acme Formulation Private Limited, Ace Testing Solutions Private Limited, Ace Invest Private Limited and 1 more | Whole-Time Director | 05 Aug 2021 | 5 Years 2 Months | Current |
| Viral Shah Also directs: Ambriel Life Sciences LLP, Acme Formulation Private Limited, Tekno Touch Private Limited and 3 more | Director | 30 Jul 2021 | 5 Years 2 Months | Current |
Auditor Details of Acme Generics Private Limited
Acme Generics Private Limited is audited by S. R. Batliboi & Co. LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. R. Batliboi & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Acme Generics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acme Generics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2025 | Hdfc Bank Limited | ₹10 Cr | Open |
| 13 Dec 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹13.36 Cr | Open |
| 13 Dec 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹17 Cr | Open |
| 13 Dec 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Cr | Open |
| 29 Mar 2024 | Hdfc Bank Limited | ₹15 Cr | Open |
Total charge records: 8 View all charges
Deals & Funding of Acme Generics Private Limited
Acme Generics Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2022.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Ace Invest Private Limited , Acme Formulation Private Limited Seller: Ace Invest Private Limited & Ruby Shah, Acme Formulation Private Limited & Viral Shah |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Acme Generics Private Limited
Acme Generics Private Limited has 5 court cases on record: 2 filed by Acme Generics, 2 filed against it, 1 where it is another party. 4 cases are pending and 1 is disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 3 |
| High courts | 2 | 0 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Company is another party | Pending |
| District court, Hapur, Uttar Pradesh | Criminal case | Filed against the company by State of U.P | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| High Court of Himachal Pradesh | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| High Court of Himachal Pradesh | Writ petition | Filed by the company against an individual | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Acme Generics Private Limited
Acme Generics Private Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 367 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 37)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Rich Offset (India) Private Limited | •••• | •••• | •••• |
| Shiv Offset (I) Pvt Ltd | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 6 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Acme Generics Private Limited
Acme Generics Private Limited has a workforce of 2,455 employees as of Apr 04, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acme Generics Private Limited
Acme Generics Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Ruby Shah ceased to be Director on 10 Aug 2021.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Acme Generics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acme Generics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acme Generics Private Limited
Acme Generics has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAVCA5625M1ZB | Himachal Pradesh | Active | 30 Jul 2021 |
| 29AAVCA5625M1ZV | Karnataka | Active | 02 Sep 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acme Generics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Acme Generics Private Limited
Frequently Asked Questions about Acme Generics Private Limited
Acme Generics is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 July 2021 (5+ years old) and is registered under CIN U24100PB2021PTC056566.
Acme Generics reported revenue of ₹263.78 Cr for FY 2024 (up 1% YoY).
Acme Generics has 2 current directors:
- Vikas Sharma - Whole-Time Director
- Viral Shah - Director
Acme Generics reported a net profit of ₹8.48 Cr (net margin 3.2%) and EBITDA of ₹23.94 Cr (EBITDA margin 9.1%) for FY 2024, as per its filed financial statements.
The GSTIN of Acme Generics is 02AAVCA5625M1ZB, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAVCA5625M1ZV (Karnataka).
The CIN (Corporate Identification Number) of Acme Generics is U24100PB2021PTC056566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acme Generics has 5 court cases on record: 2 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Acme Generics was incorporated on 30 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chandigarh.
Acme Generics has 1 deal on record (1 secondary share transfer); the latest was in March 2022.
Ruby Shah ceased to be Director on 10 Aug 2021. Vikas Sharma was appointed as Whole-Time Director on 05 Aug 2021. Vikas Sharma ceased to be Additional Director on 05 Aug 2021. Acme Generics has 4 board changes on record in total.
Acme Generics has 6 MSME Form 1 returns on record between 2022 and 2024, listing 367 overdue payments to 37 micro and small suppliers. The latest return was filed on 23 Apr 2024.